Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01035632 · ClinicalTrials.gov registry record

Study of Smoking Abstinence

A clinical trial, sponsored by National Institute on Drug Abuse (NIDA).

Completed
Registry status
210
Enrollment target

NCT01035632 is a clinical trial that has completed, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 210 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01035632 has completed, sponsored by National Institute on Drug Abuse (NIDA).

COMPLETED
Registry status
210 participants
Enrollment target

Study Summary

Background: \- Relapse following cigarette abstinence remains a common problem for smokers who are attempting to quit. Most research has focused on the acute withdrawal phase that occurs within the first 48 hours to 1 week after quitting; however, more information is needed on the experiences of smokers in longer durations of abstinence. Objectives: * To study the effects of long-term smoking abstinence. * To study the effects of cigarette-related cues on craving in longer periods of smoking abstinence. Eligibility: \- Individuals at least 18 years of age who are current smokers (at least 10 cigarettes per day) and who want to quit but are not currently attempting to quit. Design: * Participants will be randomly assigned to abstain from all nicotine use for 7, 14, or 35 days. A fourth group of participants will also abstain for 35 days, but will undergo more testing sessions than the other groups. * All participants will have an initial orientation session in which they will complete questionnaires about their smoking habits and will respond to smoking-related cues to provide information about their cravings. * Participants will visit the clinic daily during their abstinence period, and provide urine and breath samples to test for tobacco use. Participants will receive compensation for every day that they do not use tobacco. * On the end day of the abstinence period, participants will return to the clinic, provide urine and breath samples, and undergo testing of their responses to smoking-related cues. Participants in the fourth group will have these tests on Days 7, 14, and 35 of abstinence; other participants will have the tests only once, at the end of their abstinence period. * After the required abstinence period, participants will enter a 5-day step-down period. They will continue to report to the clinic for breath and urine testing, and they will receive payments for abstinence that decrease in value across days. * After the step-down period, for the f

Trial Details

FieldValue
Enrollment Target 210 participants
Start Date 2006-04-07
Est. Completion 2011-01-12

What the Registry Record Tells You About NCT01035632

The ClinicalTrials.gov registry entry for NCT01035632 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 210 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute on Drug Abuse (NIDA), which has 335 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT01035632 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01035632 about?

NCT01035632 is a clinical study titled "Study of Smoking Abstinence". Background: \- Relapse following cigarette abstinence remains a common problem for smokers who are attempting to quit. Most research has focused on the acute withdrawal phase that occurs within the first 48 hours to 1 week after quitting; however, more information is needed on the experiences of sm...

What is the current status of trial NCT01035632?

This trial is currently completed. The enrollment target is 210 participants. The study started on 2006-04-07. Estimated completion is 2011-01-12.

Who is sponsoring clinical trial NCT01035632?

This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.